(ZS) Zscaler - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US98980G1022
Stock: Cloud Security, Network Security, Data Protection, Threat Protection
Total Rating 36
Risk 79
Buy Signal 0.00
| Risk 5d forecast | |
|---|---|
| Volatility | 41.2% |
| Relative Tail Risk | -4.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -49.58 |
| Character TTM | |
|---|---|
| Beta | 1.477 |
| Beta Downside | 1.223 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.39% |
| CAGR/Max DD | 0.20 |
EPS (Earnings per Share)
Revenue
Description: ZS Zscaler March 05, 2026
Zscaler, Inc. (ZS) is a cloud security company offering a range of cyberthreat protection, data security, and security operations products globally.
The company specializes in Zero Trust security models, a framework that assumes no user or device should be trusted by default, regardless of whether they are inside or outside the network perimeter. This approach is increasingly adopted in the cybersecurity sector due to evolving threat landscapes.
Zscalers product portfolio includes Zscaler Internet Access, Zscaler Private Access, Zero Trust Firewall, and various data loss prevention (DLP) solutions. They also provide security operations products like Risk360 and managed detection and response services.
Zscaler serves diverse industries, including automotive, financial services, healthcare, and technology. The Software as a Service (SaaS) business model is prevalent in the cloud security industry, enabling recurring revenue streams.
For more detailed financial analysis and competitive insights, consider exploring ValueRays comprehensive research tools.
Headlines to watch out for
- Cloud security demand drives Zscalers revenue growth
- Increased competition pressures Zscalers pricing power
- Cybersecurity spending trends impact Zscalers sales
- Data privacy regulations influence Zscalers product development
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -67.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.09 > 1.0 |
| NWC/Revenue: 70.30% < 20% (prev 25.45%; Δ 44.85% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.11b > Net Income -67.6m |
| Net Debt (661.6m) to EBITDA (137.7m): 4.80 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (159.7m) vs 12m ago 3.91% < -2% |
| Gross Margin: 76.54% > 18% (prev 0.78%; Δ 7.58k% > 0.5%) |
| Asset Turnover: 51.04% > 50% (prev 48.38%; Δ 2.66% > 0%) |
| Interest Coverage Ratio: 0.04 > 6 (EBITDA TTM 137.7m / Interest Expense TTM 10.4m) |
Altman Z'' 1.17
| A: 0.31 (Total Current Assets 4.45b - Total Current Liabilities 2.34b) / Total Assets 6.75b |
| B: -0.18 (Retained Earnings -1.24b / Total Assets 6.75b) |
| C: 0.00 (EBIT TTM 396k / Avg Total Assets 5.88b) |
| D: -0.27 (Book Value of Equity -1.22b / Total Liabilities 4.56b) |
| Altman-Z'' Score: 1.17 = BB |
Beneish M -2.87
| DSRI: 0.87 (Receivables 551.8m/514.3m, Revenue 3.00b/2.42b) |
| GMI: 1.01 (GM 76.54% / 77.68%) |
| AQI: 1.44 (AQ_t 0.24 / AQ_t-1 0.17) |
| SGI: 1.24 (Revenue 3.00b / 2.42b) |
| TATA: -0.17 (NI -67.6m - CFO 1.11b) / TA 6.75b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of ZS shares?
As of March 19, 2026, the stock is trading at USD 156.00 with a total of 2,314,668 shares traded.
Over the past week, the price has changed by +1.42%, over one month by -9.38%, over three months by -32.50% and over the past year by -22.62%.
Over the past week, the price has changed by +1.42%, over one month by -9.38%, over three months by -32.50% and over the past year by -22.62%.
Is ZS a buy, sell or hold?
Zscaler has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy ZS.
- StrongBuy: 24
- Buy: 9
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the ZS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 234.8 | 50.5% |
| Analysts Target Price | 234.8 | 50.5% |
ZS Fundamental Data Overview March 15, 2026
P/E Forward = 40.3226
P/S = 8.238
P/B = 11.2585
P/EG = 2.0178
Revenue TTM = 3.00b USD
EBIT TTM = 396k USD
EBITDA TTM = 137.7m USD
Long Term Debt = 1.70b USD (from longTermDebt, last quarter)
Short Term Debt = 67.6m USD (from shortTermDebt, last quarter)
Debt = 1.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 661.6m USD (from netDebt column, last quarter)
Enterprise Value = 23.07b USD (24.72b + Debt 1.86b - CCE 3.51b)
Interest Coverage Ratio = 0.04 (Ebit TTM 396k / Interest Expense TTM 10.4m)
EV/FCF = 24.45x (Enterprise Value 23.07b / FCF TTM 943.7m)
FCF Yield = 4.09% (FCF TTM 943.7m / Enterprise Value 23.07b)
FCF Margin = 31.45% (FCF TTM 943.7m / Revenue TTM 3.00b)
Net Margin = -2.25% (Net Income TTM -67.6m / Revenue TTM 3.00b)
Gross Margin = 76.54% ((Revenue TTM 3.00b - Cost of Revenue TTM 704.1m) / Revenue TTM)
Gross Margin QoQ = 76.55% (prev 76.56%)
Tobins Q-Ratio = 3.42 (Enterprise Value 23.07b / Total Assets 6.75b)
Interest Expense / Debt = 0.23% (Interest Expense 4.22m / Debt 1.86b)
Taxrate = 21.0% (US default 21%)
NOPAT = 313k (EBIT 396k * (1 - 21.00%))
Current Ratio = 1.90 (Total Current Assets 4.45b / Total Current Liabilities 2.34b)
Debt / Equity = 0.85 (Debt 1.86b / totalStockholderEquity, last quarter 2.20b)
Debt / EBITDA = 4.80 (Net Debt 661.6m / EBITDA 137.7m)
Debt / FCF = 0.70 (Net Debt 661.6m / FCF TTM 943.7m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.15% (Net Income -67.6m / Total Assets 6.75b)
RoE = -3.48% (Net Income TTM -67.6m / Total Stockholder Equity 1.95b)
RoCE = 0.01% (EBIT 396k / Capital Employed (Equity 1.95b + L.T.Debt 1.70b))
RoIC = 0.01% (NOPAT 313k / Invested Capital 3.51b)
WACC = 10.58% (E(24.72b)/V(26.59b) * Re(11.36%) + D(1.86b)/V(26.59b) * Rd(0.23%) * (1-Tc(0.21)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.31%
[DCF] Terminal Value 73.36% ; FCFF base≈844.1m ; Y1≈1.04b ; Y5≈1.77b
[DCF] Fair Price = 117.8 (EV 19.60b - Net Debt 661.6m = Equity 18.94b / Shares 160.8m; r=10.58% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 33.00 | EPS CAGR: 60.83% | SUE: 1.64 | # QB: 1
Revenue Correlation: 98.82 | Revenue CAGR: 32.15% | SUE: 3.33 | # QB: 11
EPS next Quarter (2026-04-30): EPS=1.01 | Chg7d=-0.000 | Chg30d=+0.064 | Revisions Net=+39 | Analysts=40
EPS current Year (2026-07-31): EPS=4.02 | Chg7d=-0.011 | Chg30d=+0.193 | Revisions Net=+41 | Growth EPS=+22.5% | Growth Revenue=+24.1%
EPS next Year (2027-07-31): EPS=4.59 | Chg7d=-0.001 | Chg30d=+0.100 | Revisions Net=+30 | Growth EPS=+14.2% | Growth Revenue=+19.7%
[Analyst] Revisions Ratio: +1.00 (39 Up / 0 Down within 30d for Next Quarter)
P/S = 8.238
P/B = 11.2585
P/EG = 2.0178
Revenue TTM = 3.00b USD
EBIT TTM = 396k USD
EBITDA TTM = 137.7m USD
Long Term Debt = 1.70b USD (from longTermDebt, last quarter)
Short Term Debt = 67.6m USD (from shortTermDebt, last quarter)
Debt = 1.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 661.6m USD (from netDebt column, last quarter)
Enterprise Value = 23.07b USD (24.72b + Debt 1.86b - CCE 3.51b)
Interest Coverage Ratio = 0.04 (Ebit TTM 396k / Interest Expense TTM 10.4m)
EV/FCF = 24.45x (Enterprise Value 23.07b / FCF TTM 943.7m)
FCF Yield = 4.09% (FCF TTM 943.7m / Enterprise Value 23.07b)
FCF Margin = 31.45% (FCF TTM 943.7m / Revenue TTM 3.00b)
Net Margin = -2.25% (Net Income TTM -67.6m / Revenue TTM 3.00b)
Gross Margin = 76.54% ((Revenue TTM 3.00b - Cost of Revenue TTM 704.1m) / Revenue TTM)
Gross Margin QoQ = 76.55% (prev 76.56%)
Tobins Q-Ratio = 3.42 (Enterprise Value 23.07b / Total Assets 6.75b)
Interest Expense / Debt = 0.23% (Interest Expense 4.22m / Debt 1.86b)
Taxrate = 21.0% (US default 21%)
NOPAT = 313k (EBIT 396k * (1 - 21.00%))
Current Ratio = 1.90 (Total Current Assets 4.45b / Total Current Liabilities 2.34b)
Debt / Equity = 0.85 (Debt 1.86b / totalStockholderEquity, last quarter 2.20b)
Debt / EBITDA = 4.80 (Net Debt 661.6m / EBITDA 137.7m)
Debt / FCF = 0.70 (Net Debt 661.6m / FCF TTM 943.7m)
Total Stockholder Equity = 1.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.15% (Net Income -67.6m / Total Assets 6.75b)
RoE = -3.48% (Net Income TTM -67.6m / Total Stockholder Equity 1.95b)
RoCE = 0.01% (EBIT 396k / Capital Employed (Equity 1.95b + L.T.Debt 1.70b))
RoIC = 0.01% (NOPAT 313k / Invested Capital 3.51b)
WACC = 10.58% (E(24.72b)/V(26.59b) * Re(11.36%) + D(1.86b)/V(26.59b) * Rd(0.23%) * (1-Tc(0.21)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.31%
[DCF] Terminal Value 73.36% ; FCFF base≈844.1m ; Y1≈1.04b ; Y5≈1.77b
[DCF] Fair Price = 117.8 (EV 19.60b - Net Debt 661.6m = Equity 18.94b / Shares 160.8m; r=10.58% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 33.00 | EPS CAGR: 60.83% | SUE: 1.64 | # QB: 1
Revenue Correlation: 98.82 | Revenue CAGR: 32.15% | SUE: 3.33 | # QB: 11
EPS next Quarter (2026-04-30): EPS=1.01 | Chg7d=-0.000 | Chg30d=+0.064 | Revisions Net=+39 | Analysts=40
EPS current Year (2026-07-31): EPS=4.02 | Chg7d=-0.011 | Chg30d=+0.193 | Revisions Net=+41 | Growth EPS=+22.5% | Growth Revenue=+24.1%
EPS next Year (2027-07-31): EPS=4.59 | Chg7d=-0.001 | Chg30d=+0.100 | Revisions Net=+30 | Growth EPS=+14.2% | Growth Revenue=+19.7%
[Analyst] Revisions Ratio: +1.00 (39 Up / 0 Down within 30d for Next Quarter)